Your browser doesn't support javascript.
loading
Characterisation of proguanylin expressing cells in the intestine - evidence for constitutive luminal secretion.
Dye, Florent Serge; Larraufie, Pierre; Kay, Richard; Darwish, Tamana; Rievaj, Juraj; Goldspink, Deborah A; Meek, Claire L; Middleton, Stephen J; Hardwick, Richard H; Roberts, Geoffrey P; Percival-Alwyn, Jennifer L; Vaughan, Tris; Ferraro, Franco; Challis, Benjamin G; O'Rahilly, Stephen; Groves, Maria; Gribble, Fiona M; Reimann, Frank.
Afiliação
  • Dye FS; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Larraufie P; Department of Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.
  • Kay R; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Darwish T; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Rievaj J; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Goldspink DA; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Meek CL; Dosage Form Design & Development, AstraZeneca, Cambridge, UK.
  • Middleton SJ; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Hardwick RH; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Roberts GP; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Percival-Alwyn JL; Barrett's Oesophagus and Oesophago-gastric Cancer, Gastroenterology Services, Addenbrooke's Hospital, Cambridge, UK.
  • Vaughan T; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Ferraro F; Department of Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.
  • Challis BG; Department of Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.
  • O'Rahilly S; Department of Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.
  • Groves M; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Gribble FM; Wellcome/MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Reimann F; Department of Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK. grovesm@medimmune.com.
Sci Rep ; 9(1): 15574, 2019 10 30.
Article em En | MEDLINE | ID: mdl-31666564
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Precursores de Proteínas / Regulação da Expressão Gênica / Hormônios Gastrointestinais / Mucosa Intestinal Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Precursores de Proteínas / Regulação da Expressão Gênica / Hormônios Gastrointestinais / Mucosa Intestinal Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido